ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Analytical Development Lead at Relay Therapeutics - ApplyBlast

Analytical Development Lead

Relay Therapeutics

3 months ago

4.0 on Glassdoor

Cambridge, Massachusetts, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

This role leads the analytical strategy and method development for small molecule drug substances, overseeing validation, transfer, and QC testing from early development through commercial readiness. The position involves managing external CDMO relationships, reviewing technical data, and driving the integration of modern analytical technologies to support regulatory filings. It requires cross-functional collaboration with CMC, Quality Assurance, and Regulatory Affairs to ensure scientific rigor and project success.

Responsibilities

Lead analytical strategy for method development and validation across drug substance programs
Direct evaluation and introduction of modern analytical technologies into development workflows
Provide senior-level review and approval of method transfer protocols and regulatory data sets

Skills

Qualifications

Ph.D. in Analytical ChemistryPh.D. in BiotechnologyMSBS

About Relay Therapeutics

relaytx.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

51-200 employees

Founded

2016

View Profile

Relay Therapeutics is a biotechnology company that puts protein motion at the heart of drug discovery, using computational modeling, machine learning, and experimental structural biology to reveal dynamic protein states and identify novel therapeutic opportunities. The company applies this platform to design and advance small‑molecule drug candidates, translating dynamic insights into lead programs and partnerships. Relay’s approach aims to expand the set of druggable targets and accelerate development of medicines across multiple disease areas.